Expanding the Infant Achievements Intervention Through Community Partnerships
Launched by HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC. · Mar 9, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The primary objective of the research study is to increase teachers' implementation of evidence-based practices in Early Head Start classrooms through the delivery of a professional development (PD) training intervention. It is hypothesized that teachers' fidelity to developmentally-appropriate practices, assessed through classroom observation measures, will increase following their participation in a comprehensive PD training intervention. The secondary hypotheses are that (1) the PD intervention is feasible to implement in an established child care program, and (2) the PD program is accep...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must currently work in an early childhood classroom serving children between 8-36 months of age.
- • Participants must work in the role of a teacher or teacher assistant in an Early Head Start location.
- • Participants must be willing to participate in two 60-90-minute trainings/workshops.
- • Participants must be willing to participate in eight follow-up job-embedded coaching sessions
- Exclusion Criteria:
- • Works in a childcare setting outside of the Baltimore metro area
- • Non-English speaking
About Hugo W. Moser Research Institute At Kennedy Krieger, Inc.
The Hugo W. Moser Research Institute at Kennedy Krieger, Inc. is a leading research institution dedicated to advancing the understanding and treatment of neurodevelopmental disorders. With a strong focus on innovative scientific research, the Institute fosters collaboration among experts in various fields, including neuroscience, genetics, and rehabilitation. By conducting rigorous clinical trials and studies, the Institute aims to translate findings into effective interventions that improve the quality of life for individuals with disabilities. Its commitment to excellence in research and patient care positions it as a pivotal player in the advancement of pediatric healthcare and therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Rebecca Landa, PhD
Principal Investigator
Kennedy Krieger Institute, Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported